/ Media

News Features

Access media kits and related information for our featured news stories.


15 May 2013 ASCO 2013:Press Releases, Fact Sheets & More We're presenting important new findings on unapproved and investigational medicines at ASCO 2013. Read press releases and learn about our presence at ASCO this year.
14 May 2013 FDA Approval: Personalized Medicine for a Specific Type of Metastatic Non-Small Cell Lung Cancer (NSCLC) as Detected by an FDA-Approved Test On May 14, 2013, the FDA approved a personalized medicine for people newly diagnosed with a genetically distinct type of metastatic NSCLC. Download Media Kit
10 May 2013 Celebrating the 60th Anniversary of Watson & Crick's Discovery Genentech built an iPad app that turns a primary genetic concept into a maddeningly addictive mobile game.
22 Feb 2013 FDA Approves New Genentech Medicine for HER2-Positive Metastatic Breast Cancer On February 22^nd, 2013, the FDA approved a new personalized Genentech medicine for people with an aggressive form of breast cancer. Download Media Kit \| Download B-Roll
23 Jan 2013 FDA Approves New Use of Genentech Medicine for People with Metastatic Colorectal Cancer On January 23, 2013, a Genentech medicine received FDA approval for a new use in metastatic colorectal cancer. Download B-Roll \| Download Media Kit
12 Oct 2012 FDA Approves Expanded Use of Genentech Medicine in Rheumatoid Arthritis On October 12, 2012, a Genentech medicine received approval from the FDA to expand its indication for Rheumatoid Arthritis. Download Media Kit
25 Aug 2012 Genentech's gRide Program Achieves Landmark Milestone gRide, Genentech's employee commuting program, has saved 100 million miles of driving since the program's inception began in late 2006. The program began as a way to reduce the number of vehicles that travel to and park on the South San Francisco campus. Watch the Video \| Download Media Kit
10 Aug 2012 Genentech Medicine Approved for Diabetic Macular Edema (DME) On August 10, 2012, a Genentech medicine was approved by the FDA for diabetic macular edema (DME). Download B-Roll \| Download Media Kit
11 June 2012 Genentech Gives Back Week 2012 Genentech Gives Back Week (June 11 - 6, 2012) is a unique opportunity for Genentech employees to support the communities where we live and work. View the Infographic
8 June 2012 Genentech Medicine Approved For HER2-Positive Metastatic Breast Cancer On June 8, 2012, a Genentech medicine was approved by the FDA for previously untreated HER2-positive metastatic breast cancer. Download B-roll \| Download Images
30 May 2012 Genentech at ASCO 2012 Genentech will present important new data on several cancer medicines at the 48th Annual Meeting of the American Society of Clinical Oncology (ASCO).
17 May 2012 Landmark Alzheimer's Prevention Trial Genentech, the Banner Alzheimer's Institute, and the National Institutes of Health are collaborating on the first-ever prevention trial in cognitively healthy individuals who are likely to develop Alzheimer's disease due to their genetic history.
30 Jan 2012 Genentech Medicine Approved For Advanced BCC On January 30, 2012, a Genentech medicine was approved by the FDA for the treatment of adults with a type of skin cancer, called basal cell carcinoma (BCC), that has spread to other parts of the body or that has come back after surgery or that their healthcare provider decides cannot be treated with surgery or radiation. Download B-roll \| Download BCC Images \| Download Product Images
17 Aug 2011 Genentech Medicine Approved For Certain Type Of Melanoma On August 17, 2011, a Genentech medicine was approved by the FDA for a type of inoperable or metastatic melanoma. Download B-roll \| Download Product Images
20 Oct 2010 Genentech Medicine Approved in Stomach Cancer On October 20, 2010, a Genentech medicine was approved by the U.S. Food and Drug Administration (FDA) for stomach cancer. Download B-roll \| Download Product Images
18 Oct 2010 25th Anniversary of First Product Approval October 18, 2010 is the 25th anniversary of Genentech's first product approval and the first recombinant biotech drug to be manufactured and marketed by a biotechnology company.
21 Sept 2010 Napoleone Ferrara Named 2010 Lasker Award Winner Genentech Fellow Napoleone Ferrara is the winner of the 2010 Lasker Award for clinical research, presented annually to an investigator "whose contributions have improved the clinical treatment of patients."
13 Sept 2010 Genentech Goes to Town 2010 Genentech Goes to Town takes place September 13 to September 24 in South San Francisco, Vacaville, Oceanside and Hillsboro. The Genentech Goes to Town program supports our communities by providing employees with special "GenenMoney" to spend at local businesses.
14 June 2012 Genentech Gives Back Week 2010 Genentech Gives Back Week voluntary activities each day that help Genentech employees collectively make a difference in our communities. All employees are invited to participate in Genentech Gives Back as their time and interest allows.
6 Apr 2010 Hillsboro Operations Ribbon Cutting On April 6, Genentech recognized the opening of its operations in Hillsboro, Oregon, home to a state-of-the-art biologic fill/finish facility and warehousing and distribution center.